Internal Medicine, Hematology & Oncology · San Antonio, TX
NPI
1013297167
Since 2011
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
7979 Wurzbach Rd
San Antonio, TX, 78229
Phone (210) 450-1143
Groups this clinician bills Medicare through
Medicare paid, 2024
$986K
46,806 services
Medicare patients, 2024
453
Average age 73
Drug cost, 2024
$12.1M
1,727 prescriptions
Company payments, 2025
$1,953
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew J Butler was code J9271 (injection, pembrolizumab, 1 mg), 6,200 times for 17 patients. In total Matthew J Butler billed 46,806 services in 111 codes, and Medicare paid $986K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 6,200 | 17 | $44.62 | $277K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2,880 | 11 | $39.39 | $113K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 2,850 | 13 | $0.11 | $315 |
| J9171 Injection, docetaxel, 1 mg | Office | 1,368 | 14 | $0.65 | $893 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,268 | 22 | $2.00 | $2,539 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 574 | 30 | $0.09 | $51.75 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 544 | 252 | $12.68 | $6,899 |
| 99214 Office E&M - Established | Office | 389 | 160 | $93.28 | $36K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 340 | 18 | $0.07 | $24.76 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 200 | 14 | $0.70 | $140 |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 177 | 20 | $2.57 | $455 |
| 96413 Chemotherapy Administration | Office | 119 | 70 | $91.76 | $11K |
| 99213 Office E&M - Established | Office | 113 | 93 | $61.48 | $6,947 |
| 96375 Injection Administration | Office | 106 | 41 | $12.32 | $1,305 |
| 99215 Office E&M - Established | Office | 86 | 60 | $136.21 | $12K |
By year: 2022 $1.3M for 52,949 services; 2023 $1.4M for 62,355 services; 2024 $986K for 46,806 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew J Butler prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 222 prescriptions and refills. In total Matthew J Butler wrote 1,727 Medicare prescriptions that cost $12.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 222 | 306 | 54 | $5,723 |
| Lenalidomide Generic | 208 | 208 | 35 | $2.7M |
| Revlimid Lenalidomide | 181 | 181 | 34 | $3.3M |
| Dexamethasone Generic | 92 | 106 | 31 | $1,007 |
| Pomalyst Pomalidomide | 86 | 86 | 19 | $1.9M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 74 | 74 | 18 | $2,341 |
| Famotidine Generic | 49 | 67 | 17 | $335 |
| Gabapentin Generic | 42 | 56 | Under 11 | $446 |
| Ondansetron Hcl Generic | 40 | 40 | 22 | $517 |
| Prochlorperazine Maleate Generic | 40 | 46 | 27 | $1,574 |
| Ninlaro Ixazomib Citrate | 39 | 39 | 11 | $525K |
| Duloxetine Hcl Generic | 38 | 50 | Under 11 | $444 |
| Calquence Acalabrutinib Maleate | 37 | 37 | Under 11 | $320K |
| Montelukast Sodium Generic | 35 | 52 | 18 | $212 |
| Venclexta Venetoclax | 35 | 35 | Under 11 | $258K |
Brand drugs: 561 claims; generic drugs: 1,166 claims; opioid claims: 141.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew J Butler $1,953 ($1,953 in general payments such as food, travel and fees) from 7 companies. The largest payer was Janssen Biotech, Inc. with $1,731.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.